Vaxart Raies $12.5 Million
Vaxart Inc., a San Francisco-based developer of oral-delivery vaccines, has raised $12.5 million in Series B funding led by Care Capital.
4 March 2010•3 mins read
Vaxart Inc., a San Francisco-based developer of oral-delivery vaccines, has raised $12.5 million in Series B funding led by Care Capital.
